Pharmaceutical Market Europe • July/August 2021 • 24
THOUGHT LEADER
By Will Maier
Increasingly, real-world evidence – information gathered as a product to be used in clinical practice – helps regulators, payers, providers and patients make informed health decisions. Research conducted outside randomised controlled trials (RCTs) can be used to monitor patient safety and measure drug utilisation as well as to fill in evidence gaps with respect to a treatment’s value and durability.
Yet, for all their useful applications, it is difficult to enrol patients in real-world studies via traditional means. Treating physicians have other higher priorities, one of which is to recruit patients into RCTs. And, since the onset of the pandemic, fewer patients are visiting healthcare professionals in person. Plus, there’s the need to include a representative sample of a large and diverse patient population; whereas pivotal clinical trials typically seek to enrol hundreds of patients, real-world studies often aim to enrol thousands, if not tens of thousands, of patients.
So, how can study sponsors reach such a large body of prospective study participants? One solution is to use digital channels for inbound, or ‘pull’ marketing. Using digital media, sponsors can put relevant study opportunities in front of people based on their geography, demographics and/or interests. Because the approach is automated, it takes place around the clock, affords broad reach, which speeds enrolment timelines, and reduces start-up costs.
Digital recruitment campaigns involve three key components that may be integrated with other tactics:
The ads direct patients who are interested in learning more to a landing page on the study website. A carefully orchestrated pathway then ushers patients through an introduction to the study, a self-screening step, an invitation to join the study if appropriate and, finally, to an electronic consent form.
Although digital recruitment is a fairly new approach, it has already been well tested, and best practices around its implementation have emerged. The most successful digital campaigns:
One company sought to conduct a natural history study of a condition, while also building a database of patients who may be interested in participating in a clinical trial in the future. A total of 8,320,000 patients viewed the targeted online ads, 9,900 completed the online screener, 6,000 patients were eligible based on the screener, and 3,000 patients actually enrolled in the study. The study met its enrolment target in under six months.
As real-world studies gain importance, study sponsors must turn to the most efficient and cost-effective means of recruiting thousands of patients. Digital recruiting is one proven answer.
‘Although digital recruitment is a fairly new approach, it has already been well tested, and best practices around its implementation have emerged’